Who buys CPB stock?
CPB stock was purchased by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Marshall Wace LLP, Goldman Sachs Group Inc., Waldron Private Wealth LLC, Squarepoint Ops LLC, Millennium Management LLC, BlackRock Inc., and Nordea Investment Management AB.
Should you hold Campbell Soup (CPB) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Campbell Soup stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CPB, but not buy additional shares or sell existing shares. View analyst ratings for Campbell Soup or view top-rated stocks.
How much will BCB Bancorp stock dividends be paid in 2022?
Get prepared with the key expectations. BAYONNE, N.J., Jan. 14, 2022 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today announced that its Board of Directors declared a regular quarterly cash dividend of $0.16 per share.
What is Campbell Soup's (CCL) stock price potential next year?
Their forecasts range from $42.00 to $54.00. On average, they expect Campbell Soup's share price to reach $45.00 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
See more
Is Campbell Soup stock a good buy?
Campbell Soup has received a consensus rating of Hold. The company's average rating score is 1.80, and is based on no buy ratings, 8 hold ratings, and 2 sell ratings.
What is the WACC of Campbells?
Campbell Soup Co WACC % As of today (2022-07-15), Campbell Soup Co's weighted average cost of capital is 3.64%.
Is Campbell Soup in financial trouble?
Based on the latest financial disclosure, Campbell Soup has a Probability Of Bankruptcy of 37.0%. This is 2.27% higher than that of the Consumer Defensive sector and 11.06% lower than that of the Packaged Foods industry.
What is your best estimate of the WACC for Kraft Foods?
The Kraft Heinz Co WACC % As of today (2022-06-06), The Kraft Heinz Co's weighted average cost of capital is 6.15%.
When is Campbell Soup's Investor Day 2021?
When will Campbell Soup report its results?
CAMDEN, N.J., November 11, 2021--Campbell Soup Company (NYSE:CPB) today announced that it will host an Investor Day on Tuesday, Dec. 14, 2021 from 9:00 a.m. EDT to approximately noon EDT. The meeting will be held virtually.
Why is Campbell Soup battling margin concerns?
CAMDEN, N.J., November 18, 2021--Campbell Soup Company (NYSE: CPB) today announced that it will report its first-quarter fiscal 2022 financial results on Dec. 8, 2021.
What is the FY 2022 earnings for Campbell Soup?
Campbell Soup (CPB) is battling margin concerns due to elevated inflation, a rise in supply-chain expenses and some executional headwinds related to the transformation plan. Management recently cut the EPS view.
When will Campbell Soup repurchase its stock?
Campbell Soup updated its FY 2022 earnings guidance on Wednesday, September, 29th. The company provided EPS guidance of $2.750-$2.850 for the period, compared to the Thomson Reuters consensus estimate of $2.870. The company issued revenue guidance of $8.31 billion-$8.48 billion, compared to the consensus revenue estimate of $8.35 billion.
What is MarketBeat community ratings?
Campbell Soup declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 1st 2021, which permits the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 3.8% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.
How much does Campbell's soup make?
MarketBeat's community ratings are surveys of what our community members think about Campbell Soup and other stocks. Vote “Outperform” if you believe CPB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CPB will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is the P/E ratio of Campbell Soup?
Campbell Soup has a market capitalization of $13.49 billion and generates $8.69 billion in revenue each year. The company earns $1.63 billion in net income (profit) each year or $2.95 on an earnings per share basis.
What is the symbol for Campbell's soup?
The P/E ratio of Campbell Soup is 12.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.75.
Does Campbell's soup have dividends?
Campbell Soup trades on the New York Stock Exchange (NYSE) under the ticker symbol "CPB."
BCB Bancorp (BCBP) is a Top Dividend Stock Right Now: Should You Buy?
Campbell Soup does not yet have a strong track record of dividend growth. The dividend payout ratio of Campbell Soup is 50.17%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Campbell Soup will have a dividend payout ratio of 51.39% next year.
Zacks.com featured highlights include: BCB Bancorp, Inc., Verra Mobility Corp., Northeast Community Bancorp, Inc. and Alithya Group Inc
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BCB Bancorp (BCBP) have what it takes? Let's find out.
4 Affordable Breakout Stocks for Stunning Returns
BCB Bancorp, Inc., Verra Mobility Corp., Northeast Community Bancorp, Inc. and Alithya Group Inc are highlighted in this Screen of the Week Article.
What is the CRBP mAb?
BCBP, VRRM, NECB, and ALYA qualified the screen for breakout stocks for today.
What is the target price of Cara Therapeutics?
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) has announced licensing deals for two new monoclonal antibodies (mAbs), CRB-601 and CRB-602, that target integrins to inhibit activation of transforming growth factor β (TGFβ). TGFβ is a multifunctional cytokine involved in many cellular processes, including cell growth and differentiation, immune responses, wound healing, and tissue repair. CRB-601 is an anti- α vβ8 mAb expressed by cancer cells. Corbus plans to develop CRB-601 to treat solid t
What is the company name of Corbus Pharmaceuticals?
CARA: Lowering target price to $11.00 CARA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
When will Corbus have four compounds?
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and reported financial results for the third quarter of 2021.